Back
Tecogen, Inc. 10K Form
Sell
13
TGEN
Tecogen, Inc.
TGEN
Tecogen, Inc.
Tecogen, Inc.
Last Price:
$2.75
Seasonality Move:
22.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | TGEN/Tecogen, Inc. Quarterly |
| 2023-11-09 | 10Q | TGEN/Tecogen, Inc. Quarterly |
| 2023-08-10 | 10Q | TGEN/Tecogen, Inc. Quarterly |
| 2023-05-11 | 10Q | TGEN/Tecogen, Inc. Quarterly |
| 2022-11-10 | 10Q | TGEN/Tecogen, Inc. Quarterly |
| 2022-08-11 | 10Q | TGEN/Tecogen, Inc. Quarterly |
Receive TGEN News And Ratings
See the #1 stock for the next 7 days that we like better than TGEN
TGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $27.1M |
|---|---|
| Cash Flow: | $-2.6M |
| Price / Cash Flow: | 142.87 |
| Annual Sales: | $0.73 |
| Price / Book: | 3.52 |
Profitability
| EPS (TTM): | -0.29220 |
|---|---|
| Net Income (TTM): | $-8.2M |
| Gross Margin: | $9.8M |
| Return on Equity: | -54.73% |
| Return on Assets: | -24.61% |
Tecogen, Inc. Earnings Forecast
Key Tecogen, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for TGEN is 36.29%.
-
The Selling, General & Administrative Expenses for TGEN have been equal to 58.32% of Gross Profit Margin.
-
The Research & Development expenses have been 4.31% of Revenue.
-
The Net Earning history of TGEN is -30.47% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 5 years.
Tecogen, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Building Products |
| Sector: | Industrials |
| Current Symbol: | TGEN |
| CUSIP: | 87876P |
| Website: | tecogen.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 3.12 |
| Quick Ratio: | 1.86 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 12.15 |
TGEN Technical Analysis vs Fundamental Analysis
Sell
13
Tecogen, Inc. (TGEN)
is a Sell
Is Tecogen, Inc. a Buy or a Sell?
-
Tecogen, Inc. stock is rated a SellThe current Tecogen, Inc. [TGEN] share price is $2.62. The Score for TGEN is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.